SHA:600211 Revenue

Tibet Rhodiola Pharmaceutical Holding Co. had revenue of 712.11M CNY in the quarter ending March 31, 2025, with 1.12% growth. This brings the company's revenue in the last twelve months to 2.81B, down -3.99% year-over-year. In the year 2024, Tibet Rhodiola Pharmaceutical Holding Co. had annual revenue of 2.81B, down -10.45%.

Revenue (ttm)

2.81B

Revenue Growth

-3.99%

P/S Ratio

4.14

Revenue / Employee

4.72M

Employees

596

Market Cap

11.65B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.81B	-327.62M	-10.45%
Dec 31, 2023	3.13B	579.72M	22.69%
Dec 31, 2022	2.55B	416.02M	19.45%
Dec 31, 2021	2.14B	765.48M	55.75%
Dec 31, 2020	1.37B	117.08M	9.32%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings